The main problem of percutaneous osseointegrated implants is poor
skin-implant integration, which may cause infection. This study investigated the
effects of pore size (Small, 40–100 microns and Large, 100–160
microns), nanotubular surface treatment (Nano), and duration of implantation (3
and 6 weeks) on skin ingrowth into porous titanium. Each implant type was
percutaneously inserted in the back of 35 rats randomly assigned to 7 groups.
Implant extrusion rate was measured weekly and skin ingrowth into implants was
determined histologically after harvesting implants. It was found that all 3
types of implants demonstrated skin tissue ingrowth of over 30% (at week 3) and
50% (at weeks 4–6) of total implant porous area under the skin; longer
implantation resulted in greater skin ingrowth (p<0.05). Only one case of
infection was observed (infection rate 2.9%). Small and Nano groups showed the
same implant extrusion rate which was lower than the Large group rate
(0.06±0.01 vs. 0.16 ± 0.02 cm/week; p<0.05). Ingrowth area
was comparable in the Small, Large and Nano implants. However, qualitatively,
the Nano implants showed greatest cellular inhabitation within first three
weeks. We concluded that percutaneous porous titanium implants allow for skin
integration with the potential for a safe seal.